|
[1]
|
中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.
|
|
[2]
|
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article 109119. https://doi.org/10.1016/j.diabres.2021.109119
|
|
[3]
|
段佩含, 修宇飞, 李建辉, 等. 中医药调节NLRP3炎症小体治疗糖尿病肾病的研究进展[J]. 中国医药导报, 2025, 22(26): 178-181, 197.
|
|
[4]
|
Chen, Y., Chen, R., Ji, X., Zeng, Z. and Guan, C. (2025) NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Targets. Journal of Inflammation Research, 18, 8399-8418. https://doi.org/10.2147/jir.s524246
|
|
[5]
|
田代华, 刘更生. 灵枢经[M]. 北京: 人民卫生出版社, 2017.
|
|
[6]
|
周嘉培, 王小平.《黄帝内经》合邪发病观辨析[J]. 中华中医药杂志, 2021, 36(9): 5233-5236.
|
|
[7]
|
张介宾. 类经[M]. 北京: 中国中医药出版社, 1997.
|
|
[8]
|
章虚谷. 灵素节注类编[M]. 浙江: 浙江科学技术出版社, 1986.
|
|
[9]
|
鲍林杨.《内经》“因加而发”的发病理论研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2019.
|
|
[10]
|
巢元方. 诸病源候论[M]. 北京: 中国医药科技出版社, 2018.
|
|
[11]
|
杨霓芝, 刘旭生. 糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案) [J]. 上海中医药杂志, 2007(7): 7-8.
|
|
[12]
|
Navarro-González, J.F., Mora-Fernández, C., de Fuentes, M.M. and García-Pérez, J. (2011) Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathy. Nature Reviews Nephrology, 7, 327-340. https://doi.org/10.1038/nrneph.2011.51
|
|
[13]
|
Vande Walle, L. and Lamkanfi, M. (2024) Drugging the NLRP3 Inflammasome: From Signalling Mechanisms to Therapeutic Targets. Nature Reviews Drug Discovery, 23, 43-66. https://doi.org/10.1038/s41573-023-00822-2
|
|
[14]
|
Zheng, F., Ma, L., Li, X., Wang, Z., Gao, R., Peng, C., et al. (2022) Neutrophil Extracellular Traps Induce Glomerular Endothelial Cell Dysfunction and Pyroptosis in Diabetic Kidney Disease. Diabetes, 71, 2739-2750. https://doi.org/10.2337/db22-0153
|
|
[15]
|
Zhang, C., Gong, Y., Li, N., Liu, X., Zhang, Y., Ye, F., et al. (2021) Long Noncoding RNA Kcnq1ot1 Promotes sC5b-9-Induced Podocyte Pyroptosis by Inhibiting miR-486a-3p and Upregulating NLRP3. American Journal of Physiology-Cell Physiology, 320, C355-C364. https://doi.org/10.1152/ajpcell.00403.2020
|
|
[16]
|
徐大椿, 万芳. 医学源流论[M]. 北京: 人民卫生出版社, 2023.
|
|
[17]
|
张介宾, 李继明. 景岳全书[M]. 北京: 人民卫生出版社, 2023.
|
|
[18]
|
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., et al. (2015) NLRP3-Inflammasome Activation in Non-Myeloid-Derived Cells Aggravates Diabetic Nephropathy. Kidney International, 87, 74-84. https://doi.org/10.1038/ki.2014.271
|
|
[19]
|
Zhang, M., Liu, W., Liu, Y., Zhang, Z., Hu, Y., Sun, D., et al. (2023) Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis. DNA and Cell Biology, 42, 594-607. https://doi.org/10.1089/dna.2023.0102
|
|
[20]
|
Han, W., Ma, Q., Liu, Y., Wu, W., Tu, Y., Huang, L., et al. (2019) Huangkui Capsule Alleviates Renal Tubular Epithelial-Mesenchymal Transition in Diabetic Nephropathy via Inhibiting NLRP3 Inflammasome Activation and TLR4/NF-κB Signaling. Phytomedicine, 57, 203-214. https://doi.org/10.1016/j.phymed.2018.12.021
|
|
[21]
|
Li, W., He, W., Xia, P., Sun, W., Shi, M., Zhou, Y., et al. (2019) Total Extracts of Abelmoschus Manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of Ros-Erk1/2-Mediated NLRP3 Inflammasome Activation. Frontiers in Pharmacology, 10, Article No. 567. https://doi.org/10.3389/fphar.2019.00567
|
|
[22]
|
Zhang, Q., Liu, X., Sullivan, M.A., Shi, C. and Deng, B. (2021) Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial‐to‐Mesenchymal Transition in db/db Mice. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 7958021. https://doi.org/10.1155/2021/7958021
|
|
[23]
|
Yi, Z., Peng, Y., Hui, B., Liu, Z., Lin, Q., Zhao, D., et al. (2023) Zuogui-Jiangtang-yishen Decoction Prevents Diabetic Kidney Disease: Intervene Pyroptosis Induced by Trimethylamine N-Oxide through the mROS-NLRP3 Axis. Phytomedicine, 114, Article 154775. https://doi.org/10.1016/j.phymed.2023.154775
|
|
[24]
|
Li, N., Zhao, T., Cao, Y., Zhang, H., Peng, L., Wang, Y., et al. (2021) Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-Pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis. Frontiers in Pharmacology, 11, Article ID: 623489. https://doi.org/10.3389/fphar.2020.623489
|
|
[25]
|
Lv, C., Cheng, T., Zhang, B., Sun, K. and Lu, K. (2023) Triptolide Protects against Podocyte Injury in Diabetic Nephropathy by Activating the NRF2/Ho-1 Pathway and Inhibiting the NLRP3 Inflammasome Pathway. Renal Failure, 45, Article 2165103. https://doi.org/10.1080/0886022x.2023.2165103
|
|
[26]
|
Ma, Z., Zhu, L., Wang, S., Guo, X., Sun, B., Wang, Q., et al. (2022) Berberine Protects Diabetic Nephropathy by Suppressing Epithelial-to-Mesenchymal Transition Involving the Inactivation of the NLRP3 Inflammasome. Renal Failure, 44, 923-932. https://doi.org/10.1080/0886022x.2022.2079525
|
|
[27]
|
Wang, T., Gao, Y., Yue, R., Wang, X., Shi, Y., Xu, J., et al. (2020) Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF‐κB/NLRP3 Axis. Evidence-Based Complementary and Alternative Medicine, 2020, Article ID: 2735714. https://doi.org/10.1155/2020/2735714
|
|
[28]
|
Yu, Q., Zhang, M., Qian, L., Wen, D. and Wu, G. (2019) Luteolin Attenuates High Glucose-Induced Podocyte Injury via Suppressing NLRP3 Inflammasome Pathway. Life Sciences, 225, 1-7. https://doi.org/10.1016/j.lfs.2019.03.073
|
|
[29]
|
Wu, Q., Guan, Y., Zhang, K., Li, L. and Zhou, Y. (2023) Tanshinone IIA Mediates Protection from Diabetes Kidney Disease by Inhibiting Oxidative Stress Induced Pyroptosis. Journal of Ethnopharmacology, 316, Article 116667. https://doi.org/10.1016/j.jep.2023.116667
|
|
[30]
|
Li, G., Liu, C., Yang, L., Feng, L., Zhang, S., An, J., et al. (2023) Syringaresinol Protects against Diabetic Nephropathy by Inhibiting Pyroptosis via NRF2-Mediated Antioxidant Pathway. Cell Biology and Toxicology, 39, 621-639. https://doi.org/10.1007/s10565-023-09790-0
|
|
[31]
|
赵沛东, 郭闫闫, 任相阁, 等. 雷公藤及其活性成分治疗糖尿病肾病的作用机制研究进展[J]. 中国实验方剂学杂志, 2026, 32(7): 352-362.
|
|
[32]
|
Jin, J. and Zhang, M. (2024) Exploring the Role of NLRP3 Inflammasome in Diabetic Nephropathy and the Advancements in Herbal Therapeutics. Frontiers in Endocrinology, 15, Article ID: 1397301. https://doi.org/10.3389/fendo.2024.1397301
|